83 parallel-processing-bioinformatics positions at Imperial College London in United Kingdom
Sort by
Refine Your Search
-
and hands-on teaching of prototyping and manufacturing techniques, including manual machine operation, to workshop users of all experience levels. To meet research and teaching project deadlines and
-
qualification (A-Level equivalent). You’ll be an enthusiastic and intrepid learner, eager to get to know the ins-and-outs of an operation when it comes to delivering events. You’re the sort of person who is happy
-
contact Dr Rajesh Bhargave, Associate Professor of Marketing, (Email: r.bhargave@imperial.ac.uk ). Should you have queries about the application process, please contact Maria Monteiro, Senior Appointments
-
substantial impact. We invite applications from candidates across specific areas of design and engineering that are related to (but not limited to) one or more of the following areas: Design and operation of
-
that focuses on increasing the opportunities for employment for the School’s 2,000+ students, by supporting the smooth and efficient running of the systems and processes of our Team. The Employer Relations Team
-
processes. By leveraging state-of-the-art digital tools, you will enhance the efficiency of the Registry while ensuring first-class service delivery that meets the evolving needs of our students and faculty
-
, including scenario-based and tube-based approaches, to ensure reliable operation despite significant uncertainty in weather, demand and energy prices. In collaboration with UK Power Networks and SSE Energy
-
and/or publication in relevant and refereed journals; Experience in object-oriented coding, for example, in astronomical data processing or cosmological simulations; Practical research experience in
-
the Molecular Science Research Hub building in west London. You will work alongside a dynamic team of researchers that span synthetic chemistry and computational modelling. Catalytic hydrogenation processes
-
when microbes such as bacteria and fungi adapt and become resistant to the drugs we use to kill them and treat infections. Such drug-resistant infections have the potential to become a global